Kwality Pharmaceuticals Share Price
13 Nov, 2026 4:01 PM (IST)
Kwality Pharmaceuticals Performance
- Today's Low
- ₹3,800
- Today's High
- ₹4,096
- 52 Week Low
- ₹852
- 52 Week High
- ₹4,220
- Open Price₹3,989
- Previous Close₹3,942
- Volume101,913
- 50 DMA₹3,535.50
- 100 DMA₹3,211.80
- 200 DMA₹2,658.00
Kwality Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 8.9%
- Over 3 Month + 15.55%
- Over 6 Month + 129.04%
- Over 1 Year + 295.77%
Smart Investing Starts Here Start SIP with Kwality Pharmaceuticals for Steady Growth!
Kwality Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 41.6
- PEG Ratio
- 0.4
- Market Cap Cr
- 3,989
- P/B Ratio
- 11.2
- Average True Range
- 218
- EPS
- 92.5
- Dividend Yield
- 0
- MACD Signal
- 93.8
- RSI
- 57.02
- MFI
- 81.22
Latest Stock News Updates
<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Kwality Pharmaceuticals announced Q2FY27 results</strong></span></h3> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIChAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="ja2xmc_1h"> <li data-complete="true" data-hveid="CAAIChAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_1i"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_1k">Revenue from Operations:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue from operations stood at Rs 18,122.29 lakh, up 11.62% QoQ from Rs 16,235.22 lakh in Q1FY27 and up 63.19% YoY from Rs 11,105.10 lakh in Q2FY26. For H1FY27, revenue from operations reached Rs 34,357.51 lakh, rising 54.40% YoY from Rs 22,253.00 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_1s">Total Income:<!--TgQPHd|||[]--></strong> For Q2FY27, total revenue stood at Rs 18,199.38 lakh, increasing 11.67% QoQ from Rs 16,297.49 lakh in Q1FY27 and 62.57% YoY from Rs 11,194.82 lakh in Q2FY26. For H1FY27, total revenue was Rs 34,496.86 lakh, growing 54.14% YoY from Rs 22,380.29 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_1y"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_20">Profit Before Tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT stood at Rs 4,221.77 lakh, up 24.22% QoQ from Rs 3,398.70 lakh in Q1FY27 and up 128.82% YoY from Rs 1,845.05 lakh in Q2FY26. For H1FY27, PBT reached Rs 7,620.48 lakh, surging 114.79% YoY from Rs 3,547.84 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_26"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_28">Profit After Tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT stood at Rs 2,902.62 lakh, growing 13.28% QoQ from Rs 2,562.23 lakh in Q1FY27 and 105.63% YoY from Rs 1,411.57 lakh in Q2FY26. For H1FY27, PAT reached Rs 5,464.85 lakh, up 109.90% YoY from Rs 2,603.55 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_2e"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_2g">Earnings Per Share (EPS):<!--TgQPHd|||[]--></strong> For Q2FY27, basic and diluted EPS stood at Rs 27.93, rising 13.12% QoQ from Rs 24.69 in Q1FY27 and 105.37% YoY from Rs 13.60 in Q2FY26. For H1FY27, basic and diluted EPS stood at Rs 52.63, up 109.76% YoY from Rs 25.09 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="ja2xmc_2w"> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_2x"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_2z">Revenue from Operations:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue from operations stood at Rs 18,116.79 lakh, up 11.59% QoQ from Rs 16,235.22 lakh in Q1FY27 and up 62.76% YoY from Rs 11,131.31 lakh in Q2FY26. For H1FY27, revenue from operations reached Rs 34,352.01 lakh, growing 54.19% YoY from Rs 22,279.20 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_30"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_32">Total Income:<!--TgQPHd|||[]--></strong> For Q2FY27, total revenue stood at Rs 18,193.88 lakh, increasing 11.64% QoQ from Rs 16,297.49 lakh in Q1FY27 and 62.14% YoY from Rs 11,221.03 lakh in Q2FY26. For H1FY27, total revenue was Rs 34,491.37 lakh, up 53.93% YoY from Rs 22,406.50 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAD" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_33"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_35">Profit Before Tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT stood at Rs 4,221.58 lakh, rising 24.20% QoQ from Rs 3,399.15 lakh in Q1FY27 and 128.80% YoY from Rs 1,845.12 lakh in Q2FY26. For H1FY27, PBT reached Rs 7,620.73 lakh, up 114.72% YoY from Rs 3,549.15 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_36"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_38">Profit After Tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT stood at Rs 2,902.42 lakh, increasing 13.26% QoQ from Rs 2,562.68 lakh in Q1FY27 and 105.61% YoY from Rs 1,411.64 lakh in Q2FY26. For H1FY27, PAT reached Rs 5,465.10 lakh, growing 109.80% YoY from Rs 2,604.86 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="ja2xmc_39"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="ja2xmc_3b">Earnings Per Share (EPS):<!--TgQPHd|||[]--></strong> For Q2FY27, basic and diluted EPS stood at Rs 27.97, up 13.24% QoQ from Rs 24.70 in Q1FY27 and up 105.66% YoY from Rs 13.60 in Q2FY26. For H1FY27, basic and diluted EPS stood at Rs 52.67, rising 109.84% YoY from Rs 25.10 in H1FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5944825/" target="_blank">Result PDF</a></p>
- Trendlyne
- 1 day 22 hours ago
Investor Presentation for the quarter and half year ended unaudited financial results for 30-09-2026
- BSE India
- 1 day 23 hours ago
Appointment of new Statutory Auditors
- BSE India
- 1 day 23 hours ago
Kwality Pharmaceuticals Financials
Kwality Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹3,695.70
- 50 Day
- ₹3,535.50
- 100 Day
- ₹3,211.80
- 200 Day
- ₹2,658.00
Resistance and Support
- R3 4,310.00
- R2 4,203.10
- R1 4,013.80
- S1 3,717.60
- S2 3,610.70
- S3 3,421.40
Kwality Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-12 | Quarterly Results | |
| 2026-08-10 | Quarterly Results | |
| 2026-05-19 | Audited Results | |
| 2026-02-12 | Quarterly Results | |
| 2025-11-13 | Quarterly Results |
About Kwality Pharmaceuticals
Kwality Pharmaceuticals is engaged in the business of manufacturers, buyers and sellers of and dealers in all kind of drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. View More- NSE Symbol
- KPL
- BSE Symbol
- 539997
- ISIN
- INE552U01010
Similar Stocks to Kwality Pharmaceuticals
Popular Stocks
Kwality Pharmaceuticals FAQs
Kwality Pharmaceuticals share price is ₹3,844 As on 14 November, 2026 | 12:02
The Market Cap of Kwality Pharmaceuticals is ₹3989.1 Cr As on 14 November, 2026 | 12:02
The P/E ratio of Kwality Pharmaceuticals is 41.6 As on 14 November, 2026 | 12:02
The PB ratio of Kwality Pharmaceuticals is 11.2 As on 14 November, 2026 | 12:02
The 52 week High & Low of Kwality Pharmaceuticals is ₹4219.8/₹852 respectively As on 14 November, 2026 | 12:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.